KRYS logo

Krystal Biotech (KRYS) Cash From Investing

Annual CFI

-$163.44 M
-$246.08 M-297.78%

December 31, 2024

Summary

Performance

1-Year Change

-297.78%

3-Year Change

+27.93%

5-Year Change

-3174.67%

15-Year Change

-77728.1%

KRYS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.18%
KRYS annual cash flow from investing activities is higher than 11.18% of companies in Healthcare sector

High & Low

All-time High

$82.64 M
KRYS annual cash flow from investing activities is currently -297.78% below its historical high of $82.64 million

3-Year Low

-$226.77 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KRYS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KRYS next annual earnings announcement has not yet been scheduled

OtherKRYScash flowmetrics:

Annual CFF

$27.01 M
KRYS annual cash flow from financing activities is $27.01 million

Annual CFO

$123.42 M
KRYS annual cash flow from operations is $123.42 million

Annual FCF

$119.18 M
KRYS annual free cash flow is $119.18 million

Annual CAPEX

$4.24 M
KRYS annual capital expenditures is $4.24 million

Quarterly CFI

-$83.78 M
-$49.45 M-144.05%

December 31, 2024

Summary

Performance

3-Month Change

-144.05%

1-Year Change

-222.47%

3-Year Change

-1508.64%

5-Year Change

-1508.64%

KRYS Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.39%
KRYS quarterly cash flow from investing activities is higher than 8.39% of companies in Healthcare sector

High & Low

All-time High

$105.19 M
KRYS quarterly cash flow from investing activities is currently -179.64% below its historical high of $105.19 million

3-Year Low

-$126.54 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KRYS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 6, 2025
KRYS next earnings announcement is scheduled for May 6, 2025

OtherKRYScash flowmetrics:

Quarterly CFF

$2.43 M
KRYS quarterly cash flow from financing activities is $2.43 million

Quarterly CFO

$52.84 M
KRYS quarterly cash flow from operations is $52.84 million

Quarterly FCF

$52.04 M
KRYS quarterly free cash flow is $52.04 million

Quarterly CAPEX

$801.00 K
KRYS quarterly capital expenditures is $801.00 thousand

TTM CFI

-$163.44 M
-$73.62 M-81.96%

December 31, 2024

Summary

Performance

3-Month Change

-81.96%

1-Year Change

-407.82%

3-Year Change

-43.26%

5-Year Change

-43.26%

KRYS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12.73%
KRYS TTM cash flow from investing activities is higher than 12.73% of companies in Healthcare sector

High & Low

All-time High

$87.59 M
KRYS TTM cash flow from investing activities is currently -286.60% below its historical high of $87.59 million

3-Year Low

-$281.93 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KRYS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 6, 2025
KRYS next earnings announcement is scheduled for May 6, 2025

OtherKRYScash flowmetrics:

TTM CFF

$27.01 M
KRYS TTM cash flow from financing activities is $27.01 million

TTM CFO

$123.42 M
KRYS TTM cash flow from operations is $123.42 million

TTM FCF

$119.18 M
KRYS TTM free cash flow is $119.18 million

TTM CAPEX

$4.24 M
KRYS TTM capital expenditures is $4.24 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KRYS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-297.8%-222.5%-407.8%
3 y3 years+27.9%-1508.6%-43.3%
5 y5 years-3174.7%-1508.6%-43.3%

KRYS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-297.8%+27.9%-179.6%+33.8%-286.6%+42.0%
5 y5-year-297.8%+27.9%-179.6%+33.8%-286.6%+42.0%
alltimeall time-297.8%+27.9%-179.6%+33.8%-286.6%+42.0%

Krystal Biotech Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$163.44 M(-297.8%)
-$83.78 M(+144.1%)
-$163.44 M(+82.0%)
Sep 2024
-
-$34.33 M(+77.4%)
-$89.82 M(-280.7%)
Jun 2024
-
-$19.35 M(-25.5%)
$49.70 M(-6.4%)
Mar 2024
-
-$25.98 M(+155.7%)
$53.09 M(-35.7%)
Dec 2023
$82.64 M(-172.4%)
-$10.16 M(-109.7%)
$82.64 M(-5.7%)
Sep 2023
-
$105.19 M(-759.2%)
$87.59 M(-370.8%)
Jun 2023
-
-$15.96 M(-547.9%)
-$32.34 M(-40.8%)
Mar 2023
-
$3.56 M(-168.4%)
-$54.61 M(-52.1%)
Dec 2022
-$114.08 M(-49.7%)
-$5.21 M(-64.7%)
-$114.08 M(-51.5%)
Sep 2022
-
-$14.74 M(-61.4%)
-$235.41 M(-8.7%)
Jun 2022
-
-$38.22 M(-31.6%)
-$257.84 M(-8.5%)
Mar 2022
-
-$55.91 M(-55.8%)
-$281.93 M(+24.3%)
Dec 2021
-$226.77 M(+1928.2%)
-$126.54 M(+240.5%)
-$226.77 M(+113.0%)
Sep 2021
-
-$37.17 M(-40.4%)
-$106.45 M(+47.9%)
Jun 2021
-
-$62.32 M(+8242.3%)
-$71.98 M(+577.6%)
Mar 2021
-
-$747.00 K(-88.0%)
-$10.62 M(-5.0%)
DateAnnualQuarterlyTTM
Dec 2020
-$11.18 M(+124.0%)
-$6.22 M(+130.5%)
-$11.18 M(+101.3%)
Sep 2020
-
-$2.70 M(+180.4%)
-$5.55 M(+56.9%)
Jun 2020
-
-$962.00 K(-26.3%)
-$3.54 M(-7.2%)
Mar 2020
-
-$1.30 M(+120.8%)
-$3.81 M(-23.6%)
Dec 2019
-$4.99 M(-51.7%)
-$591.00 K(-13.3%)
-$4.99 M(-38.9%)
Sep 2019
-
-$682.00 K(-44.8%)
-$8.17 M(-20.2%)
Jun 2019
-
-$1.24 M(-50.2%)
-$10.24 M(-20.0%)
Mar 2019
-
-$2.48 M(-34.1%)
-$12.80 M(+24.0%)
Dec 2018
-$10.32 M(+4815.7%)
-$3.77 M(+36.7%)
-$10.32 M(+53.7%)
Sep 2018
-
-$2.75 M(-27.5%)
-$6.71 M(+69.1%)
Jun 2018
-
-$3.80 M(<-9900.0%)
-$3.97 M(+1856.7%)
Mar 2018
-
$0.00(-100.0%)
-$203.00 K(-3.3%)
Dec 2017
-$210.00 K(+1300.0%)
-$159.00 K(+1225.0%)
-$210.00 K(+311.8%)
Sep 2017
-
-$12.00 K(-62.5%)
-$51.00 K(+30.8%)
Jun 2017
-
-$32.00 K(+357.1%)
-$39.00 K(+457.1%)
Mar 2017
-
-$7000.00
-$7000.00
Dec 2016
-$15.00 K
-
-

FAQ

  • What is Krystal Biotech annual cash flow from investing activities?
  • What is the all time high annual CFI for Krystal Biotech?
  • What is Krystal Biotech annual CFI year-on-year change?
  • What is Krystal Biotech quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Krystal Biotech?
  • What is Krystal Biotech quarterly CFI year-on-year change?
  • What is Krystal Biotech TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Krystal Biotech?
  • What is Krystal Biotech TTM CFI year-on-year change?

What is Krystal Biotech annual cash flow from investing activities?

The current annual CFI of KRYS is -$163.44 M

What is the all time high annual CFI for Krystal Biotech?

Krystal Biotech all-time high annual cash flow from investing activities is $82.64 M

What is Krystal Biotech annual CFI year-on-year change?

Over the past year, KRYS annual cash flow from investing activities has changed by -$246.08 M (-297.78%)

What is Krystal Biotech quarterly cash flow from investing activities?

The current quarterly CFI of KRYS is -$83.78 M

What is the all time high quarterly CFI for Krystal Biotech?

Krystal Biotech all-time high quarterly cash flow from investing activities is $105.19 M

What is Krystal Biotech quarterly CFI year-on-year change?

Over the past year, KRYS quarterly cash flow from investing activities has changed by -$57.80 M (-222.47%)

What is Krystal Biotech TTM cash flow from investing activities?

The current TTM CFI of KRYS is -$163.44 M

What is the all time high TTM CFI for Krystal Biotech?

Krystal Biotech all-time high TTM cash flow from investing activities is $87.59 M

What is Krystal Biotech TTM CFI year-on-year change?

Over the past year, KRYS TTM cash flow from investing activities has changed by -$216.53 M (-407.82%)